Atossa Therapeutics Inc (MEX:ATOS) Stock News, Headlines & Updates
Atossa Therapeutics Inc Stock News from GuruFocus
- 1
Jun 06, 2025
Atossa Therapeutics (ATOS): Ascendiant Capital Raises Price Target | ATOS Stock News
GuruFocus News • 6:30am
Jun 05, 2025
Craig-Hallum Initiates Coverage on Atossa Therapeutics (ATOS) with Buy Rating | ATOS Stock News
GuruFocus News • 12:31pm
Atossa Therapeutics (ATOS) Receives Buy Rating with Promising Cancer Drug Potential | ATOS Stock News
GuruFocus News • 8:00am
Atossa Therapeutics (ATOS) Receives Positive Coverage and Price Target | ATOS Stock News
GuruFocus News • 6:30am
Jun 02, 2025
Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference | ATOS Stock News
GuruFocus News • 8:00am
Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference
PRNewswire • 8:00am
May 20, 2025
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22
ACCESSWIRE • 11:00am
Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | ATOS Stock News
GuruFocus News • 8:18am
May 14, 2025
Atossa Therapeutics (ATOS) Reports Promising Phase 2 Trial Results | ATOS Stock News
GuruFocus News • 8:15am
Atossa Therapeutics Announces Full Results from I?SPY?2 Endocrine?Optimization Sub?Study Evaluating Low?Dose (Z)?Endoxifen
PRNewswire • 8:00am
Atossa Therapeutics Announces Full Results from I?SPY?2 Endocrine?Optimization Sub?Study Evaluating Low?Dose (Z)?Endoxifen | ATOS Stock News
GuruFocus News • 7:30am
May 13, 2025
Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update
PRNewswire • 8:00am
Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update | ATOS Stock News
GuruFocus News • 7:18am
May 02, 2025
ATOS: Atossa Therapeutics Secures New Patent for (Z)-endoxifen Formulations | ATOS Stock News
GuruFocus News • 11:15am
Apr 30, 2025
Atossa Therapeutics (ATOS) Secures Patent for Key Breast Cancer Drug Formulations
GuruFocus News • 1:58pm
Atossa Therapeutics (ATOS) Secures Patent for Innovative Drug Formulations | ATOS Stock News
GuruFocus News • 8:54am
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio | ATOS Stock News
GuruFocus News • 8:15am
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio
Marketwired • 8:00am
Apr 29, 2025
Atossa Therapeutics (ATOS) Launches SMART 2.0 Phase 3 Clinical Study | ATOS Stock News
GuruFocus News • 8:15am
Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025 | ATOS Stock News
GuruFocus News • 8:15am
Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025
Marketwired • 8:00am
Apr 22, 2025
Atossa Therapeutics (ATOS) Secures New U.S. Patent for (Z)-endoxifen Formulations
GuruFocus News • 9:00am
Atossa Therapeutics (ATOS) Secures Patent for New (Z)-endoxifen Formulation | ATOS Stock News
GuruFocus News • 8:15am
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio | ATOS Stock News
GuruFocus News • 8:00am
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio
Marketwired • 8:00am
Apr 10, 2025
Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer
PRNewswire • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news